<?xml version='1.0' encoding='utf-8'?>
<document id="26376025"><sentence text="Subcutaneous L-tyrosine elicits cutaneous analgesia in response to local skin pinprick in rats."><entity charOffset="13-23" id="DDI-PubMed.26376025.s1.e0" text="L-tyrosine" /></sentence><sentence text="The purpose of the study was to estimate the ability of L-tyrosine to induce cutaneous analgesia and to investigate the interaction between L-tyrosine and the local anesthetic lidocaine"><entity charOffset="56-66" id="DDI-PubMed.26376025.s2.e0" text="L-tyrosine" /><entity charOffset="140-150" id="DDI-PubMed.26376025.s2.e1" text="L-tyrosine" /><entity charOffset="176-185" id="DDI-PubMed.26376025.s2.e2" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s2.e0" e2="DDI-PubMed.26376025.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s2.e0" e2="DDI-PubMed.26376025.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26376025.s2.e0" e2="DDI-PubMed.26376025.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26376025.s2.e1" e2="DDI-PubMed.26376025.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26376025.s2.e1" e2="DDI-PubMed.26376025.s2.e2" /></sentence><sentence text=" After subcutaneously injecting the rats with L-tyrosine and lidocaine in a dose-dependent manner, cutaneous analgesia (by blocking the cutaneous trunci muscle reflex-CTMR) was evaluated in response to the local pinprick"><entity charOffset="46-56" id="DDI-PubMed.26376025.s3.e0" text="L-tyrosine" /><entity charOffset="61-70" id="DDI-PubMed.26376025.s3.e1" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s3.e0" e2="DDI-PubMed.26376025.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s3.e0" e2="DDI-PubMed.26376025.s3.e1" /></sentence><sentence text=" The drug-drug interaction was analyzed by using an isobolographic method" /><sentence text=" We showed that both L-tyrosine and lidocaine produced dose-dependent cutaneous analgesia"><entity charOffset="21-31" id="DDI-PubMed.26376025.s5.e0" text="L-tyrosine" /><entity charOffset="36-45" id="DDI-PubMed.26376025.s5.e1" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s5.e0" e2="DDI-PubMed.26376025.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s5.e0" e2="DDI-PubMed.26376025.s5.e1" /></sentence><sentence text=" On the 50% effective dose (ED50) basis, the rank of drug potency was lidocaine (5"><entity charOffset="70-79" id="DDI-PubMed.26376025.s6.e0" text="lidocaine" /></sentence><sentence text="09 [4" /><sentence text="88-5" /><sentence text="38] μmol)&gt;L-tyrosine (39"><entity charOffset="0-20" id="DDI-PubMed.26376025.s9.e0" text="38] μmol)&gt;L-tyrosine" /></sentence><sentence text="1 [36" /><sentence text="5-41" /><sentence text="8] μmol) (P&lt;0" /><sentence text="05)" /><sentence text=" At the equipotent doses (ED25, ED50, and ED75), the duration of cutaneous analgesia caused by L-tyrosine lasted longer than that caused by lidocaine (P&lt;0"><entity charOffset="95-105" id="DDI-PubMed.26376025.s14.e0" text="L-tyrosine" /><entity charOffset="140-149" id="DDI-PubMed.26376025.s14.e1" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s14.e0" e2="DDI-PubMed.26376025.s14.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s14.e0" e2="DDI-PubMed.26376025.s14.e1" /></sentence><sentence text="01)" /><sentence text=" Lidocaine co-administered with L-tyrosine exhibited an additive effect on infiltrative cutaneous analgesia"><entity charOffset="1-10" id="DDI-PubMed.26376025.s16.e0" text="Lidocaine" /><entity charOffset="32-42" id="DDI-PubMed.26376025.s16.e1" text="L-tyrosine" /><pair ddi="false" e1="DDI-PubMed.26376025.s16.e0" e2="DDI-PubMed.26376025.s16.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s16.e0" e2="DDI-PubMed.26376025.s16.e1" /></sentence><sentence text=" Our pre-clinical study demonstrated that L-tyrosine elicits the local/cutaneous analgesia, and the interaction between L-tyrosine and lidocaine is additive"><entity charOffset="42-52" id="DDI-PubMed.26376025.s17.e0" text="L-tyrosine" /><entity charOffset="120-130" id="DDI-PubMed.26376025.s17.e1" text="L-tyrosine" /><entity charOffset="135-144" id="DDI-PubMed.26376025.s17.e2" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s17.e0" e2="DDI-PubMed.26376025.s17.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s17.e0" e2="DDI-PubMed.26376025.s17.e1" /><pair ddi="false" e1="DDI-PubMed.26376025.s17.e0" e2="DDI-PubMed.26376025.s17.e2" /><pair ddi="false" e1="DDI-PubMed.26376025.s17.e1" e2="DDI-PubMed.26376025.s17.e1" /><pair ddi="false" e1="DDI-PubMed.26376025.s17.e1" e2="DDI-PubMed.26376025.s17.e2" /></sentence><sentence text=" L-tyrosine has a lower potency but much greater duration of cutaneous analgesia than lidocaine"><entity charOffset="1-11" id="DDI-PubMed.26376025.s18.e0" text="L-tyrosine" /><entity charOffset="86-95" id="DDI-PubMed.26376025.s18.e1" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s18.e0" e2="DDI-PubMed.26376025.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s18.e0" e2="DDI-PubMed.26376025.s18.e1" /></sentence><sentence text=" Adding L-tyrosine to lidocaine preparations showed greater duration of cutaneous analgesia compared with lidocaine alone"><entity charOffset="8-18" id="DDI-PubMed.26376025.s19.e0" text="L-tyrosine" /><entity charOffset="22-31" id="DDI-PubMed.26376025.s19.e1" text="lidocaine" /><entity charOffset="106-115" id="DDI-PubMed.26376025.s19.e2" text="lidocaine" /><pair ddi="false" e1="DDI-PubMed.26376025.s19.e0" e2="DDI-PubMed.26376025.s19.e0" /><pair ddi="false" e1="DDI-PubMed.26376025.s19.e0" e2="DDI-PubMed.26376025.s19.e1" /><pair ddi="false" e1="DDI-PubMed.26376025.s19.e0" e2="DDI-PubMed.26376025.s19.e2" /><pair ddi="false" e1="DDI-PubMed.26376025.s19.e1" e2="DDI-PubMed.26376025.s19.e1" /><pair ddi="false" e1="DDI-PubMed.26376025.s19.e1" e2="DDI-PubMed.26376025.s19.e2" /></sentence><sentence text="" /></document>